Instructions for Infagel (interferon alfa-2b) gel for local and external use
English Product Name Infagel
Infagel
Release Form
Gel for local and outdoor use
Description Infagel
Gel for local and external use in the form of uniform mass of white or white with a grayish shade of color; it is allowed to delaminate the contents of the package, disappearing when shaking.
1 g
human recombinant interferon alpha 2b 10,000 ME
Auxiliary substances: aluminum hydroxide - 57.8 mg, polyvinyl alcohol - from 17.5 mg, purified water - up to 1 g.
ATX Codes
L03AB05 Interferon alfa-2b
Clinical-pharmacological groups / Group affiliation
Antiviral drug for external use
Active substance
human recombinant interferon alpha 2b
Pharmacotherapeutic group Infagel
IBP-cytokine
Retention conditions
The product shall be transported and stored in accordance with the requirements of SP 3.3.2.1248-03, in a light-protected place inaccessible to children at temperatures from 0 to 10°C.
Expiry Date
Shelf life - two years.
Expired drug should not be used.
Pharmacological effect Infagel
The recombinant interferon alpha-2b gel has a wide spectrum of antiviral activity, bacteriostatic and anti-inflammatory action, as well as antineotumor and immunomodulatory activity.
Indications Infagel
treatment of herpetic lesions of the skin and mucous: simple and rinsing herpes; recurrent herpes of the face, genitals, gingivitis, herpetic stomatitis;
prevention of influenza and ARVI in adults who have had contact with influenza and ARVI patients.
Method, course and dosage Interferon alfa
When treating herpetic lesions, the gel is applied to the affected skin and mucous areas in a thin layer 2 times/day at intervals of 12 h and dried for 10-15 minutes to form a protective film. The duration of the treatment is from 3 to 5 days, until the total disappearance of the skin and mucous membrane disorders.
In order to prevent influenza and ARVI during the periods of increase of morbidity, the drug is applied on the mucous membrane of the nasal passages 2 times/day with an interval of 12 hours during the first and third week of the course, in the second week take a break.
- Nosology Interferon alfa (ICD codes)
- A60
- Anogenic herpetic viral infection [herpes simplex]
- B00
- Infections caused by herpes simplex virus
- B00.2
- Herpetic Gingivostomatitis and Pharingotonsilitis
- B02
- Dildo [herpes zoster]
- J06.9
- Acute infection of the upper respiratory tract is unspecified
- J10
- A flu caused by an identified seasonal flu virus
- Z29.8
- Other refined preventive measures
